PENTAX Medical acquires C2 Therapeutics

PENTAX Medical, a division of HOYA Group, acquired C2 Therapeutics, developer of the C2 CryoBalloon Ablation System for endoscopic ablation of Barrett's esophagus. The acquisition amount was undisclosed.

“PENTAX Medical, a division of the HOYA Group, Tokyo, Japan announced today that they have acquired C2 Therapeutics, Redwood City, CA for an undisclosed amount.”prnewswire.com

• 1 source
• prnewswire.comPENTAX Medical Expands Interventional Endoscopy Offering with Acquisition of C2 TherapeuticsHOYA Corporation PENTAX MedicalJan 9, 2017

Summarized from public sources; check the original articles before acting on it.